薬物関連骨髄炎の潜在的なリスクシグナル:FDAの有害事象報告システム (FAERS) データベースに基づく包括的な不均衡性分析
Duoqin Huang1, Liulin Fu2, Yining Wang3
1The First Clinical Medical College, Gannan Medical University, Ganzhou, 341000, Jiangxi, China.
Naunyn-Schmiedeberg's archives of pharmacology
|February 16, 2026
まとめ
この研究では,カンナグリフロジンとアレンドロニン酸を含む20の薬物を,薬物誘発性骨髄炎の重要な危険因子として特定しました. 研究結果は,薬剤による骨感染症の早期発見と理解を助けます.
科学分野:
- 医薬品監視 医薬品監視
- 感染症 感染症は感染症です.
- 骨の代謝についてです.
背景:
- ほとんどの薬剤に関連する骨髄炎のリスクは不明である.
- 既存の研究では,特定の薬剤と骨髄炎との関連が示唆されています.
- 薬物誘発性骨髄炎のリスクシグナルを特定するために,大規模なデータ分析が必要である.
研究 の 目的:
- 薬物誘発性骨髄炎の潜在的なリスクシグナルを調査する.
- FAERSデータベースからの大規模なデータセットを分析します.
- 骨髄炎のリスクの増加に関連する特定の薬物を特定します.
主な方法:
- 2004年1Qから2025年2QまでのFAERSデータを活用した.
- 4つのアルゴリズムROR,PRR,BCPNN,MGPSを採用しました.
- ボンフェロニ補正による単変数および多変数回帰分析を実施しました.
主要な成果:
- 827種類の薬剤を特定し,18819件の骨髄炎を報告した.
- 4つのアルゴリズムによって41の薬物が一貫してフラグ付けされました.
- 多変量分析により,20の薬物 (カナグリフロジン,アレンドロニン酸,デノスマブ,メトトレキサートなど) が有意なリスクシグナルとして特定されました.
結論:
- 年齢,性別,および20の特定の薬は,薬物誘発性骨髄炎の重要なリスク要因です.
- 発症までの平均期間は350日であり,薬剤の種類によって発症時期が異なっていた.
- この発見は,早期の臨床診断と,薬物関連性骨髄炎の病原性に関する将来の研究を支援します.
キーワード:
予期せぬ有害事象は,有害事象によって引き起こされる.FAERSのデータベースは,FAERSのデータベースです.オステオミエライト (骨髄炎)医薬品監視 医薬品監視安全性分析 安全性分析についてさらに関連する動画
09:09Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
9.4K
07:48High Spatial Resolution Chemical Imaging of Implant-Associated Infections with X-ray Excited Luminescence Chemical Imaging Through Tissue
Published on: September 30, 2022
1.7K
関連する概念動画
Pharmacovigilance
1.8K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Drug Toxicity: Risk factors
18
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
18
FDA Approved Drugs: Changes to Approved Drugs
279
Post-approval, manufacturers may modify an approved new or generic drug product. Such modifications can encompass alterations in the Active Pharmaceutical Ingredient (API), manufacturing process, formulation, batch size, manufacturing site, and container closure system (FDA Guidance for Industry, April 2004). Often, a drug product may undergo multiple changes.These modifications require careful evaluation to determine their potential impact on the drug product's identity, strength, quality,...
279
Pharmaceutical Poisoning: Potential Scenarios
15
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
15
Drug Regulation
3.1K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.1K
Drug Toxicity: Overview
18
Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
18
